Amgen Announces Major Price Cut For Its Breakthrough Cholesterol Drug

By Grace-Marie Turner— The Trump administration continues to work overtime to lower prescription drug costs for consumers.  In response, some pharmaceutical companies have announced rollbacks of price increases, cuts in prices, price freezes, or other ways to improve affordability for patients. In the latest example, Amgen, a leading biologics company, is stepping forward to...

House Repeal and Replace Bill Contains Important Conservative Reforms

Voting against “repeal” could be the death knell for Republicans in 2018 The American Health Care Act is taking fire from all sides, not the least from the circular firing squad conservatives have formed, threatening passage of the only piece of repeal and replace legislation that House leaders say will be presented to members...

More Competition is the Best Cure

The most interesting thing about the PR disaster involving Mylan’s life-saving EpiPen is probably the least discussed—namely that drugs don’t cost what people think they do. Faced with a barrage of criticism for EpiPen price hikes, from about $100 in 2009 to more than $600 today, Mylan’s CEO Heather Bresch explains that her company gets less...

How Uber Will Redefine Healthcare

My Twitter pal and founding partner of Forthright Health Management, Tom Valenti, wrote in TechCrunch that “there will never be an Uber for healthcare” because “ealthcare is not a transaction business; it is a relationship business.” I’ll respectfully disagree: Healthcare “Ubers” are already proliferating and will ultimately reshape 21st-century medicine. The more aspects of healthcare we can...

Poll study top page

In A Politically Polarized Year, Poll Finds Wide Agreement Among Voters On A Key Health Care Agenda

A new poll of voters in battleground states finds a rare opportunity for bipartisan agreement on health care, with Americans strongly favoring action on public policies that support medical discovery into new treatments and cures. The poll was jointly commissioned by the Galen Institute and Center Forward, center-right and center-left think tanks. Purple Insights interviewed 800...